All Stories

  1. Association of OSMR Gene Variants rs2278329 and rs2292016 with Dermatomyositis and Systemic Lupus Erythematosus in Bulgarian Patients
  2. Darier’s Disease: A Case Report and Review of Literature
  3. Granulomatous Cheilitis of Miescher and Lingua Plicata as an Oligosymptomatic Form of Melkersson–Rosenthal Syndrome: Case Report and Review of Literature
  4. Overlap Syndromes in Autoimmune Connective Tissue Diseases
  5. Lues maligna and HIV mimicking aggressive epidermotropic CD8+ cutaneous T-cell lymphoma
  6. COVID ‐19 vaccine‐related eruption of papules and plaques—A case report
  7. Cutaneous manifestations of aortoiliac occlusive disease: two cases and review of the literature
  8. Cutaneous Manifestations and Their Corresponding Dermoscopic Features in Patients with Dermatomyositis
  9. Reticulated atrophic skin lesions in an adult patient with dermatomyositis and antinuclear matrix protein-2 autoantibodies
  10. Histology of Skin Alterations in Lupus Erythematosus
  11. Atopic Dermatitis: From Etiology and History to Treatment
  12. Herpes Simplex Associated Erythema Multiforme: A Case Report and Review of the Literature
  13. The role of IL-17 rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 SNPs and IL-17A serum levels in patients with lupus nephritis
  14. Ultraviolet diagnostic and treatment modalities in the coronavirus disease 2019 pandemic
  15. CD3Z polymorphisms and promoter hypermethylation in dermatomyositis - the role of cytosine-phosphate-guanine-related single nucleotide polymorphisms
  16. Autoimmune connective tissue diseases in the COVID-19 pandemic
  17. Graham-Little-Piccardi-Lassueur Syndrome: Two Case Reports and Review of the Literature
  18. A boy with linear hyperpigmented atrophic plaques
  19. Lupus erythematosus tumidus in an adolescent with beta thalassemia minor successfully controlled with hydroxychloroquine
  20. Recurrent MVD mutation in European patients with disseminated porokeratosis
  21. Klippel-Trenaunay Syndrome Involving Upper Limb and Chest Wall: A Case Report and Review of the Literature
  22. Neurofibromatosis Type I (Von Recklinghausen Disease): A Case Report and Review of the Literature
  23. Pseudo‐ainhum in a patient with CREST syndrome
  24. Correlation of Disease Activity and Quality of Life of Patients with Psoriasis after Narrow-band Ultraviolet B Therapy
  25. Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process
  26. XRCC1 variants do not represent a risk for dermatomyositis and systemic lupus erythematosus in Bulgarian patients
  27. Genetically Determined TNF-α Secretion Influences the Development of Dermatomyositis and Systemic Lupus Erythematosus
  28. Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology
  29. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects
  30. Danko Katalin
  31. Inflammatory Myopathies with Cutaneous Involvement
  32. Association of vitamin D receptor geneBsmI B/b andFokI F/f polymorphisms with adult dermatomyositis and systemic lupus erythematosus
  33. Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
  34. Monoclonal Antibody treatment for SLE
  35. Complications of injected vitamin E as a filler for lip augmentation: case series and therapeutic approach
  36. Oil-Soluble Vitamins: Illegal Use for Lip Augmentation
  37. Association between estrogen receptor-α gene polymorphisms and dermatomyositis in Bulgarian patients
  38. IL-1RN SNP in SLE and DM patients
  39. MBL secreting SNPs in SLE and DM patients
  40. Nevus Comedonicus: An Updated Review
  41. Role of the Promoter Polymorphism IL-6 −174G/C in Dermatomyositis and Systemic Lupus Erythematosus
  42. Perforating Disseminated Necrobiosis Lipoidica Diabeticorum
  43. Clinical variants, stages, and management of basal cell carcinoma
  44. TNF-Alpha SNPs in SLE and DM patients
  45. Sarcoidosis and molecular mimicry—important etiopathogenetic aspects: current state and future directions
  46. Abstracts from EIR School ES01-ES25
  47. IL-10 Single Nucleotide Polymorphisms and Lupus-Nephritis
  48. The Coexistence of Systemic Lupus Erythematosus and Thyrotoxicosis: The Diagnostic Value of Antihistone Antibodies
  49. Quantitative Structure-Activity Relationship Modeling of Dermatomyositis Activity of Drug Chemicals
  50. Dresdner Dermatologische Demonstration 2009 – zugleich Tagung der Sächsischen Dermatologischen Gesellschaft am 7. März 2009
  51. Dermatomyositis
  52. Paraneoplastic dermatological manifestation of gastrointestinal malignancies
  53. Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations
  54. Assen Dourmishev, MD, PhD, DSc, FAAD (1938-2006): Leader of Bulgarian dermatology
  55. Ivermectin: pharmacology and application in dermatology
  56. Segmental ulcerative vasculitis: a cutaneous manifestation of Takayasu's arteritis
  57. Syphilis: Uncommon presentations in adults
  58. Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects
  59. Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis
  60. Dermatomyositis: cutaneous manifestations of its variants
  61. D-Penicillamine induced polymyositis and morphea in a woman with Hashimoto thyroiditis
  62. Waardenburg syndrome
  63. Dermatomyositis and Drugs
  64. Dermatomyositis Associated with Malignancy
  65. Efficacy and tolerance of oral ivermectin in scabies
  66. Efficacy and tolerance of oral ivermectin in scabies
  67. Oral ivermectin in scabies patients
  68. Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin
  69. P169 Oral treatment of scabies
  70. Basal and Squamous Cell Carcinoma: Sex, Age and Location Distribution
  71. Basal and squamous cell carcinoma
  72. Dermatomyositis: a retrospective study of 34 inpatients